Is 1+1<2? Exploring Disinhibition Theory and Malaria Prevention Interventions in Angola
Implementation of health education strategies, interventions and programs
Planning of health education strategies, interventions, and programs
Public health or related education
Describe the frequency with which insecticide-treated bednets (ITNs) and indoor residual spraying (IRS) are used in conjunction in individual households in Angola, where, as with many sub-Saharan African countries, malaria is a leading cause of morbidity and mortality among children under 5, and explore whether ITNs are less likely to be used (i.e., slept under) in households with IRS compared to in households without IRS (i.e., whether IRS might disinhibit adherence to ITNs). Discuss the possibility that deploying prevention interventions simultaneously (within the context of the prevention of malaria specifically and with respect to other disease cases) may be less effective than expected due to disinhibition effects--or the possibility that the easier, more convenient intervention is cannibalizing (or disinihbiting) adherence to the other intervention. Demonstrate how knowledge of malaria may modify susceptibility to disinhibition exhibited in the relationship between having sprayed walls and using a bednet--and whether a similar relationship may exist between various other risk factors and disease related outcomes. Discuss the role of concepts from fields like psychology, behavioral economics, and decision science may improve epidemiological modeling.
Keyword(s): Epidemiology, Behavioral Research
Qualified on the content I am responsible for because: As a graduate student in public health, I have conducted several studies of various health outcomes using secondary data. My focus has narrowed to the application of concepts from behavioral economics and psychology in the formulation of epidemiological models of disease for the improvement of disease prevention and communication strategies.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.